DK0798002T3 - Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose - Google Patents

Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose

Info

Publication number
DK0798002T3
DK0798002T3 DK97106298T DK97106298T DK0798002T3 DK 0798002 T3 DK0798002 T3 DK 0798002T3 DK 97106298 T DK97106298 T DK 97106298T DK 97106298 T DK97106298 T DK 97106298T DK 0798002 T3 DK0798002 T3 DK 0798002T3
Authority
DK
Denmark
Prior art keywords
growth factor
restenosis
treatment
derived growth
platelet derived
Prior art date
Application number
DK97106298T
Other languages
English (en)
Inventor
Russell Ross
Michael A Reidy
Elaine W Raines
Volkhard Lindner
Gordon A A Ferns
Christopher Jackson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of DK0798002T3 publication Critical patent/DK0798002T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97106298T 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose DK0798002T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64175891A 1991-01-17 1991-01-17

Publications (1)

Publication Number Publication Date
DK0798002T3 true DK0798002T3 (da) 2002-08-19

Family

ID=24573729

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97106298T DK0798002T3 (da) 1991-01-17 1992-01-17 Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose
DK92905617.4T DK0573510T3 (da) 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92905617.4T DK0573510T3 (da) 1991-01-17 1992-01-17 Antivækstfaktor antistoffer i behandlingen af vaskulær stenose

Country Status (10)

Country Link
US (1) US5648076A (da)
EP (2) EP0798002B1 (da)
JP (2) JP3667752B2 (da)
AT (2) ATE216592T1 (da)
AU (1) AU665529B2 (da)
CA (1) CA2100876A1 (da)
DE (2) DE69232579T2 (da)
DK (2) DK0798002T3 (da)
ES (2) ES2174144T3 (da)
WO (1) WO1992012734A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
WO1996040250A2 (en) * 1995-06-07 1996-12-19 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
WO1998035697A1 (en) * 1997-02-14 1998-08-20 Roche Diagnostics Gmbh Improved method for the reduction of neointima formation after angioplasty
DE60226253T2 (de) * 2001-06-28 2009-05-14 Kyowa Hakko Kogyo Co., Ltd. Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
EP2060270A3 (en) * 2003-10-16 2009-12-09 Imclone LLC Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
US9339593B2 (en) * 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
US20080172124A1 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
WO2016149103A1 (en) * 2015-03-13 2016-09-22 The Regents Of The University Of California Monoclonal antibody for prevention and/or treatment of astrovirus disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288687B1 (en) * 1987-03-03 1994-12-28 Takeda Chemical Industries, Ltd. Monoclonal antibody, hybridoma, their production and use thereof
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
US5268358A (en) * 1988-12-08 1993-12-07 Cor Therapeutics, Inc. PDGF receptor blocking peptides
WO1991006668A1 (en) * 1989-10-27 1991-05-16 The Du Pont Merck Pharmaceutical Company Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
AU1327492A (en) 1992-08-27
EP0573510B1 (en) 1998-04-01
EP0798002A1 (en) 1997-10-01
EP0573510A1 (en) 1993-12-15
DE69232579T2 (de) 2002-08-22
JPH06504551A (ja) 1994-05-26
DE69224983T2 (de) 1998-07-30
ATE216592T1 (de) 2002-05-15
ES2174144T3 (es) 2002-11-01
DE69232579D1 (de) 2002-05-29
DK0573510T3 (da) 1998-04-27
JP2002316945A (ja) 2002-10-31
ATE164521T1 (de) 1998-04-15
DE69224983D1 (de) 1998-05-07
ES2117046T3 (es) 1998-08-01
JP3667752B2 (ja) 2005-07-06
EP0798002B1 (en) 2002-04-24
US5648076A (en) 1997-07-15
AU665529B2 (en) 1996-01-11
CA2100876A1 (en) 1992-07-18
WO1992012734A1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
DE69220355D1 (de) Selbstausspreizbare, vaskuläre Endoprothese
FI934176A7 (fi) Suoniproteesi
ITTO930940A0 (it) Innesto protesico vascolare
FI924814A0 (fi) Medicinska aotergivningsanordning foer roentgenbild med automatisk exponeringsfunktion
NO861624L (no) Roerformet proteseartikkel.
DE69419804D1 (de) Ortsfeste Gefässprothese
EP0550482A4 (en) Methods for inhibiting rejection of transplanted tissue
DE69105713D1 (de) Prothetische femorale komponente.
DE69632390D1 (de) Implantierbare vaskuläre und endoluminale Stents
DE69431457D1 (de) Intravaskuläre Stents
DE69736343D1 (de) Vaskuläre und endoluminale Stents
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
FI934915L (fi) Stoed foer hjaertventilprotes
DK0798002T3 (da) Anti-blodpladeafledtvækstfaktor-antistoffer til behandling af restenose
SE8803472D0 (sv) Anvaendning av gamma-interferon foer behandling av vaskulaer stenos
DE69104180D1 (de) Prothetische kniescheibekomponente.
EP0667870A4 (en) COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF--g(b).
FI940773A0 (fi) Menetelmä mäntyöljyjen valmistamiseksi
NO912091D0 (no) Fremgangsmaate for inhibering av avleiringer og avleiringsinhiberende sammensetning.
DE69322564D1 (de) Künstliches Blutgefäss
EP0458581A3 (en) Release surfaces and release tapes e.g. for diapers or nappies
DK0661981T3 (da) Anvendelse af hyaluronsyre og derivater heraf til forebyggelse mod arteriel restenose
DK0551729T3 (da) gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO932346D0 (no) Sluttstykke for ammunisjons-utkastingsroer med tilhoerende utkastingsroer